Korea South
Medility, operating under the brand PillEye, is at the forefront of digital transformation in the pharmacy sector. Established in 2020 in Korea South, this pharma tech startup leverages artificial intelligence to streamline the pill-counting process, enhancing operational efficiency in healthcare settings globally.
Their flagship product, PillEye, boasts a remarkable 99.999% accuracy in detecting and counting all pill types, significantly reducing manual workloads for pharmacists. With over 410,000 users across 225 countries, it has saved over 1,260,000 hours for healthcare providers till June 2023.
In its recent Seed Round investment on 03 July 2023, Medility secured KRW5.60B from notable investors such as Kakao Ventures, KB Investments, Korea Development Bank, and BA Partners. With a vision to further influence digital transformation in clinics and hospitals, Medility is a compelling prospect for investors seeking innovation in healthcare technology.
